Frank Kochinke, Phd Email & Phone Number

Aprimus is a novel diagnostics company. Our patented tests provide quantitative results in minutes at a low cost and in a convenient manner. Clinical studies for the d-Dimer test are expected to start in Q1/2023. In the mean time we are advancing our cancer and other biomarker tests. The Gen2 diagnostics/monitoring tests are geared towards advancing the State-of-the-Art in Mental Health Evaluation on a "chemical level" providing objective measurements compared to subjective "questionnaires". We strongly believe that combining our diagnostics/monitoring tools with the advanced drug delivery systems of Mycrodose Therapeutics is the ticket to a drastically improved well-being and mental health.

Support and work with pharmaceutical, medical and biotechnological start-up companies.

Mycrodose is the leading Advanced Drug Delivery company in the field of Mental Health Care using Psychedelics and other API's to improve the life's of many. Our SoCal Carlsbad facility will be focused on R&D of Schedule 1 controlled-release drugs (psilocybin, LSD, MDMA and DMT) and clinical supply manufacture of transdermal therapeutic systems. The move to the larger facility will allow us to grow and manufacture our own proprietary psychedelic API's. Our NorCal Silicon Valley facility will focus on the manufacture of Schedule 3 drugs, especially ketamine based products.

Co-founded EuroWound to commercialize an unique series of medical products, where other treatment approaches have failed to resolve non-healing, chronic wounds. First product is scheduled to be launched within a year.

San Francisco, California, Us

• Scientific and technological partnership with UCSF to address Oral/Systemic connection. • Setting up GMP manufacturing for clinical studies • Preparation of NIH grants

• Envisioned the fundamental concepts of Nuvora’s overall mission and vision• Responsible for all scientific and technological efforts, including medical and regulatory tasks• Heavily involved with the Company’s marketing and sales orientation and fund raising activities. Company positioned for sale to big pharma

Phd, Chemical Engineering

Ms, Physics

Bs, Physics, Mathematics